Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Sep;83(1):65-72.
doi: 10.1007/BF00223199.

Reductive methylation of lysine residues of botulinum neurotoxin types A and B

Affiliations

Reductive methylation of lysine residues of botulinum neurotoxin types A and B

V Sathyamoorthy et al. Mol Cell Biochem. 1988 Sep.

Abstract

Reductive methylation of botulinum neurotoxin (NT) serotypes A and B at various ratios of protein to reagent modified up to 75% of the lysine residues. Amino acid analysis of the modified proteins (HCl hydrolysed) confirmed selective modifications of lysine. The derivative N,N-dimethyl lysine was more abundant than monomethyl lysine; trimethyl lysine was not detected. Distribution of modified lysine residues among the heavy and light chains (Mr approximately 100,000 and approximately 50,000, respectively) of the dichain type A NT (Mr approximately 150,000) was approximately proportional to the lysine contents of the two subunit chains of the NT. Toxicity (mouse lethality) and serological reactivity (polyclonal antibody) of serotype A NT were not (or insignificantly) damaged following methylation of up to 72 lysine residues. Modification of 3 additional residues caused precipitous loss in toxicity. Toxicity of serotype B NT, unlike type A, appeared more sensitive to lysine modification. The large number of lysine residues that can be methylated without damaging toxicity of type A NT can be exploited to a) radiolabel the dichain protein exclusively in one chain keeping the other chain unlabelled, b) restrict the number of tryptic cleavage sites of the NT, and c) tag the protein with various markers or reactive ligands.

PubMed Disclaimer

Similar articles

References

    1. J Pharmacol Exp Ther. 1984 Apr;229(1):182-7 - PubMed
    1. Annu Rev Biochem. 1985;54:597-629 - PubMed
    1. J Biol Chem. 1985 Sep 5;260(19):10461-6 - PubMed
    1. Jpn J Med Sci Biol. 1981 Apr;34(2):61-8 - PubMed
    1. Biochem Biophys Res Commun. 1969 Sep 24;37(1):59-65 - PubMed

Publication types

LinkOut - more resources